Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Latest filing published 17 Sept 2026 for Vera Therapeutics, Inc., €46k. Read the official filing
Filing timeline
BuySaleMarshall Fordyce
Insider track record
Disclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Marshall Fordyce: trading record in brief
Marshall Fordyce is a declared insider of Vera Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 12 August 2022 and 15 September 2026, the trades on record add up to 51 filings.
On the market, this insider has only sold: 23 sales, €8.1M in total. No amount is published for 2 filings, which the totals therefore leave out. The rest of the record consists of 4 share grants and 24 option exercises. So far in 2026, the count stands at no purchases and 20 sales.
The latest filing, published on 17 September 2026, reports an open-market sale of €593k in Vera Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Marshall Fordyce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
18,500 shares@ US$2.89680.0022% mcap0.6% of flowClass A Common StockSEC:0001859453-26-000015:0
18,500 shares@ US$37.000.028% mcap8.2% of flowClass A Common StockSEC:0001859453-26-000015:1
18,500 shares@ US$2.89680.0022% mcap0.7% of flowClass A Common StockSEC:0001859453-26-000014:0
18,500 shares@ US$35.11580.026% mcap8.5% of flowClass A Common StockSEC:0001859453-26-000014:1
32,550 shares@ US$42.07360.061% mcap15.5% of flowClass A Common StockSEC:0001859453-26-000013:2
1,000 shares@ US$40.77620.0018% mcap0.5% of flowClass A Common StockSEC:0001859453-26-000013:1
10,500 shares@ US$42.85780.020% mcap5.1% of flowClass A Common StockSEC:0001859453-26-000013:3
2,200 shares@ US$43.59470.0043% mcap1.1% of flowClass A Common StockSEC:0001859453-26-000013:4
18,500 shares@ US$2.89680.6% of flowClass A Common StockSEC:0001859453-26-000011:0
14,219 shares@ US$36.63965.7% of flowClass A Common StockSEC:0001859453-26-000011:1
4,281 shares@ US$37.08681.8% of flowClass A Common StockSEC:0001859453-26-000011:2
18,500 shares@ US$2.89680.0024% mcap0.6% of flowClass A Common StockSEC:0001859453-26-000012:0
18,412 shares@ US$37.93110.031% mcap7.9% of flowClass A Common StockSEC:0001859453-26-000012:1
88 shares@ US$38.430.0002% mcap0.0% of flowClass A Common StockSEC:0001859453-26-000012:2
46,250 shares@ US$2.89680.0060% mcap1.5% of flowClass A Common StockSEC:0001859453-26-000013:0
32,550 shares@ US$42.07360.060% mcap29.9% of flowClass A Common StockSEC:0001859453-26-000010:1
1,000 shares@ US$40.77620.0018% mcap0.9% of flowClass A Common StockSEC:0001859453-26-000010:0
10,500 shares@ US$42.85780.020% mcap9.8% of flowClass A Common StockSEC:0001859453-26-000010:2
2,200 shares@ US$43.59470.0042% mcap2.1% of flowClass A Common StockSEC:0001859453-26-000010:3
18,412 sharesClass A Common StockSEC:0001859453-26-000008:0
88 sharesClass A Common StockSEC:0001859453-26-000008:1
14,130 shares@ US$43.66490.020% mcap22.7% of flowClass A Common StockSEC:0001859453-26-000006:0
7,921 shares@ US$44.57840.012% mcap13.0% of flowClass A Common StockSEC:0001859453-26-000006:1
900 shares@ US$45.51140.0013% mcap1.5% of flowClass A Common StockSEC:0001859453-26-000006:2
16,925 shares@ US$41.983913.0% of flowClass A Common StockSEC:0001859453-26-000004:0
25 of 51 declarations
